LOGIN  |  REGISTER
Viking Therapeutics
Amneal Pharmaceuticals

Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream

June 16, 2025 | Last Trade: US$1.77 0.03 -1.67

MIAMI, June 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal, announces the schedule of the 83rd Emerging Growth Conference on June 17 & 18, 2025.

The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

Register for the Conference here.

Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.

For updates, follow us on Twitter

Day 1
June 17, 2025

8:45
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.

9:00
Introduction

9:05 – 9:35
51Talk Online Education Group (NYSE American: COE)
Keynote speaker: Jiajia Huang, Founder, Chairman, CEO

9:40 – 10:10
ASP Isotopes Inc. (NASDAQ: ASPI)
Keynote speaker: Paul Elliot Mann, CEO

12:00 – 12:30
Ur-Energy (NYSE American: URG) (TSX: URE)
Keynote speaker: John W. Cash, CEO

12:35 – 1:05
Waypoint 2 Space
Keynote speaker: Kevin M. Heath, Chief Executive Officer

1:45 – 2:15
Sono Group N.V. (OTCQB: SEVCF)
Keynote speaker: George O’Leary, Managing Director, CEO and CFO

2:55 – 3:05
Odyssey Marine Exploration, Inc. (NASDAQ: OMEX)
Keynote speaker: Mark D. Gordon, Chairman & CEO

3:10 - 3:20
Interstellar Communication Holdings
Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard  of IcMercury, and Lijie Zhu, Captain of icMercury

3:25 - 3:35
Peloton Minerals Corp. (OTCQB: PMCCF) (CSE: PMC)
Keynote speaker: Edward L. Ellwood, President, CEO & Director

3:40 – 3:50
Aethlon Medical, Inc. (NASDAQ: AEMD)
Keynote speakers: Jim Frakes, CEO and CFO

_______________________

Day 2
June 18, 2025

8:45
Virtual Lobby opens.
Register for the Conference. If you already registered, go back to the registration link and click “Already registered” and enter your email.

9:00
Introduction

9:05 – 9:35
NewGen Digital (NASDAQ: NIVF)
Keynote speaker: Siu Wing Fung Alfred, Founder, Chairman, and CEO

9:40 – 10:10
Jaguar Health, Inc. (NASDAQ: JAGX)
Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

10:15 – 10:45
Excorp Medical, Inc.
Keynote speaker: Dan Miller, President, CEO

11:25 – 11:55
Star Gold Corp. (OTCQB: SRGZ)
Keynote speaker: Lindsay E. Gorrill, Chairman & CEO

12:35 – 1:05
Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) 
Keynote speaker: Kimberly Ann Arntson, President / CEO

1:10 – 1:40
Nova Minerals Limited (NASDAQ: NVA) (ASX: NVA)
Keynote speaker: Christopher Gerteisen – CEO & Executive Director

1:45 - 2:15
Surface Metals Inc. (OTCQB: SURMF) (CSE: SUR)
Keynote speaker: Steve Hanson, President & CEO

2:55 – 3:05
Vista Gold Corp. (NYSE American: VGZ) (TSX: VGZ)
Keynote speaker: Frederick Earnest – CEO

3:10 - 3:20
Thumzup Media Corporation (NASDAQ: TZUP)
Keynote speaker: Robert Steele, CEO

3:25 – 3:35
Regen BioPharma Inc. (OTC Pink: RGBP)
Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

3:40 – 3:50
Bioxytran, Inc. (OTCQB: BIXT) 
Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

4:10 – 4:20
Cyios Corp. (OTC Pink: CYIO)
Keynote speaker: John O’Shea, Chairman

Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

Register for the Conference here.

Submit Questions for any of the presenting companies to:
This email address is being protected from spambots. You need JavaScript enabled to view it.

Replays: Subscribe to our YouTube Channel

About EmergingGrowth.com

Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

About the Emerging Growth Conference

The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on www.EmergingGrowth.com

If you believe or know of a company that might fit our audience, contact us here.

Thank you for your interest in our conference, and we look forward to your participation in future conferences.

Contact:

Emerging Growth
Phone: 1-305-330-1985
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page